Alpha-Pryme Regeneris Protocol™ Ltd
Advanced Trans-Follicular Neogenesis & Cellular Reactivation
COMPANY STATUS: Currently engaged in closed Phase I clinical evaluation.
CLINICAL DATA: Is currently under a strict non-disclosure embargo and is not publicly available